HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. 

HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 60 trade sales and IPOs since inception.

HBM Partners is regulated by FINMA and advises SIX listed HBM Healthcare Investments and further specialised public and private equity investment products. 


Banking

HBM Partners

Andreas Wicki

Priyanka Belawat

Giammaria Giuliani

Dr. Alexander Asam

Chandra P. Leo

Matthias Fehr

Ivo Staijen

Erwin Troxler

The Leadership Team at HBM Partners is responsible for setting the strategic direction and vision of the company, overseeing investment decisions in the biopharma and healthcare sectors, and ensuring operational excellence. Comprised of the CEO and CFOs, this team drives organizational growth, fosters relationships with stakeholders, and manages compliance with regulatory bodies like FINMA, ensuring the firm stays at the forefront of value creation in its investments.

Leadership Team

Equity Team

��

Leadership Team

About

Team members

Other teams at HBM Partners

Equity Team

��������

Leadership Team

About

Team members

Other teams at HBM Partners

Equity Team

��